|
| |
Accurate quantification, forecasting and accrual of Net Product Sales ("Gross to Net Revenue") presents a daunting operational challenge for executives in the pharmaceutical industry. The need for a reliable reporting platform for monthly results, an effective forecasting tool with accurate accrual methodology and a mechanism for monthly measurement of the effectiveness of discounting and other channel management strategies simply eludes many companies. This creates significant exposure to financial risk and earnings volatility.
Skysis and Howard Roark Consulting have combined their industry-specific expertise, process development, and data-mining capabilities to develop and launch a branded service offering that directly addresses the issues associated with Net Product Sales in the pharmaceutical industry.
|
| |
ExperNET is not a "one size fits all" automated software product, but rather a Proprietary Process Framework that facilitates the complete and accurate capture of the key data sets necessary to measure and manage Net Product Sales.
The key deliverables generated from the ExperNET process framework include:
Dashboard reporting necessary to understand various discounting and channel management strategies.
Financial Reporting outcomes that drive accurate quantification and forecasting of Net Product Sales.
|
 |
|
